Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

Chin Neoh, Danny Liew, Monica Slavin, Debbie Marriott, Sharon C A Chen, Orla Morrissey, Kay Stewart, David Kong

Research output: Contribution to journalComment / DebateOther


There was an error in this paper. The correct value of life-years (LYs) saved should have been 0.62, rather than 0.53, meaning the incremental cost-effectiveness ratio (ICER) should have been AU$22003/LY saved, rather than AU$25740/LY saved. The revised ICER remains well below the implicit ICER threshold value for cost-effectiveness in Australia (AU$76000/LY saved), and, hence, the conclusion of the study is unchanged. The authors apologize for this error.
Original languageEnglish
Pages (from-to)1052
Number of pages1
JournalJournal of Antimicrobial Chemotherapy
Issue number4
Publication statusPublished - Apr 2012

Cite this